These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29386483)

  • 21. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.
    Xia H; Gao X; Gu G; Liu Z; Hu Q; Tu Y; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
    Int J Pharm; 2012 Oct; 436(1-2):840-50. PubMed ID: 22841849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.
    Kamei N; Kikuchi S; Takeda-Morishita M; Terasawa Y; Yasuda A; Yamamoto S; Ida N; Nishio R; Takayama K
    J Pharm Sci; 2013 Feb; 102(2):469-79. PubMed ID: 23160942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides.
    Khafagy el-S; Morishita M; Takayama K
    Int J Pharm; 2010 Mar; 388(1-2):209-12. PubMed ID: 20060451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach using functional peptides for efficient intestinal absorption of insulin.
    Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
    J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug delivery.
    Liu C; Tai L; Zhang W; Wei G; Pan W; Lu W
    Mol Pharm; 2014 Apr; 11(4):1218-27. PubMed ID: 24521351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
    Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
    Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
    Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H
    Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin.
    Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM
    J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse.
    Kamei N; Tanaka M; Choi H; Okada N; Ikeda T; Itokazu R; Takeda-Morishita M
    Mol Pharm; 2017 Mar; 14(3):916-927. PubMed ID: 28094952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.
    Kamei N; Morishita M; Takayama K
    J Control Release; 2009 Jun; 136(3):179-86. PubMed ID: 19250953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
    Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. d-Polyarginine Lipopeptides as Intestinal Permeation Enhancers.
    Garcia J; Fernández-Blanco Á; Teixidó M; Sánchez-Navarro M; Giralt E
    ChemMedChem; 2018 Oct; 13(19):2045-2052. PubMed ID: 30063113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereochemistry and Intermolecular Interactions Influence Carrier Peptide-Mediated Insulin Delivery.
    Diedrichsen RG; Tuelung PS; Foderà V; Nielsen HM
    Mol Pharm; 2023 Feb; 20(2):1202-1212. PubMed ID: 36607603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
    Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
    Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CPP mediated insulin delivery: current status and promising future.
    Liu E; Sheng J; Ye J; Wang Y; Gong J; Yang VC; Wang J; He H
    Curr Pharm Biotechnol; 2014; 15(3):240-55. PubMed ID: 25312540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies.
    Rehmani S; Dixon JE
    Peptides; 2018 Feb; 100():24-35. PubMed ID: 29412825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.